[1] L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes, T.I.W. Group, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, 45 Suppl S (2007) S5-67.
[2] J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, M. Buchbinder, R. Dave, G. Ansel, A. Lansky, E. Cristea, T.J. Collins, J. Goldstein, M.R. Jaff, R. Investigators, Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial, Circ Cardiovasc Interv, 3 (2010) 267-276.
[3] M. Schillinger, S. Sabeti, P. Dick, J. Amighi, W. Mlekusch, O. Schlager, C. Loewe, M. Cejna, J. Lammer, E. Minar, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115 (2007) 2745-2749.
[4] M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, W. Mlekusch, O. Schlager, M. Cejna, J. Lammer, E. Minar, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354 (2006) 1879-1888.
[5] H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Burgelin, D. Scheinert, K.L. Schulte, E. Minar, P. Peeters, M. Bosiers, G. Tepe, B. Reimers, F. Mahler, T. Tubler, T. Zeller, Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST), Circulation, 116 (2007) 285-292.
[6] H.Q. Zhao, A. Nikanorov, R. Virmani, R. Jones, E. Pacheco, L.B. Schwartz, Late stent expansion and neointimal proliferation of oversized Nitinol stents in peripheral arteries, Cardiovasc Intervent Radiol, 32 (2009) 720-726.
[7] D. Stoeckel, A. Pelton, T. Duerig, Self-expanding nitinol stents: material and design considerations, Eur Radiol, 14 (2004) 292-301.
[8] W.A. Gray, A. Feiring, M. Cioppi, R. Hibbard, B. Gray, Y. Khatib, D. Jessup, W. Bachinsky, E. Rivera, J. Tauth, R. Patarca, J. Massaro, H.P. Stoll, M.R. Jaff, S.S. Investigators, S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes, J Vasc Interv Radiol, 26 (2015) 21-28.
[9] L. Garcia, M.R. Jaff, C. Metzger, G. Sedillo, A. Pershad, F. Zidar, R. Patlola, R.G. Wilkins, A. Espinoza, A. Iskander, G.S. Khammar, Y. Khatib, R. Beasley, S. Makam, R. Kovach, S. Kamat, L.R. Leon, Jr., W.B. Eaves, J.J. Popma, L. Mauri, D. Donohoe, C.C. Base, K. Rosenfield, S.T. Investigators, Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial, Circ Cardiovasc Interv, 8 (2015).
[10] R.O. Tadros, P.L. Faries, K.J. Rocha-Singh, S. Kim, R.K. Malik, S.H. Ellozy, M.L. Marin, A.G. Vouyouka, The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial, Ann Vasc Surg, 28 (2014) 1-9.
[11] A.J. Klein, S.J. Chen, J.C. Messenger, A.R. Hansgen, M.E. Plomondon, J.D. Carroll, I.P. Casserly, Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement, Catheter Cardiovasc Interv, 74 (2009) 787-798.
[12] M. Schillinger, E. Minar, Past, present and future of femoropopliteal stenting, J Endovasc Ther, 16 Suppl 1 (2009) I147-152.
[13] M. Early, C. Lally, P.J. Prendergast, D.J. Kelly, Stresses in peripheral arteries following stent placement: a finite element analysis, Comput Methods Biomech Biomed Engin, 12 (2009) 25-33.
[14] S.H. Cha, M.H. Han, Y.H. Choi, C.J. Yoon, S.K. Baik, S.J. Kim, K.H. Chang, Vascular responses in normal canine carotid arteries: comparison between various self-expanding stents of the same unconstrained size, Invest Radiol, 38 (2003) 95-101.
[15] E.C. Kirsch, M.S. Khangure, P. Morling, T.J. York, W. McAuliffe, Oversizing of self-expanding stents: influence on the development of neointimal hyperplasia of the carotid artery in a canine model, AJNR Am J Neuroradiol, 23 (2002) 121-127.
[16] A.M. Saguner, T. Traupe, L. Raber, N. Hess, Y. Banz, A.R. Saguner, N. Diehm, O.M. Hess, Oversizing and restenosis with self-expanding stents in iliofemoral arteries, Cardiovasc Intervent Radiol, 35 (2012) 906-913.
[17] H. Cho, M. Nango, Y. Sakai, E. Sohgawa, K. Kageyama, S. Hamamoto, T. Kitayama, A. Yamamoto, Y. Miki, Neointimal hyperplasia after stent placement across size-discrepant vessels in an animal study, Jpn J Radiol, 32 (2014) 340-346.
[18] R.S. Schwartz, K.C. Huber, J.G. Murphy, W.D. Edwards, A.R. Camrud, R.E. Vlietstra, D.R. Holmes, Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model, J Am Coll Cardiol, 19 (1992) 267-274.
[19] L.H. Timmins, C.A. Meyer, M.R. Moreno, J.E. Moore, Jr., Mechanical modeling of stents deployed in tapered arteries, Ann Biomed Eng, 36 (2008) 2042-2050.
[20] P. Dick, H. Wallner, S. Sabeti, C. Loewe, W. Mlekusch, J. Lammer, R. Koppensteiner, E. Minar, M. Schillinger, Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions, Catheter Cardiovasc Interv, 74 (2009) 1090-1095.
[21] M. Fujihara, M. Utsunomiya, A. Higashimori, Y. Yokoi, M. Nakamura, Outcomes of Zilver PTX stent implantation for the treatment of complex femoropopliteal artery disease, Heart Vessels, 31 (2016) 152-157.
[22] E. Dordoni, A. Meoli, W. Wu, G. Dubini, F. Migliavacca, G. Pennati, L. Petrini, Fatigue behaviour of Nitinol peripheral stents: the role of plaque shape studied with computational structural analyses, Med Eng Phys, 36 (2014) 842-849.
[23] M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, H.B. Smouse, T. Zeller, G.S. Roubin, M.W. Burket, Y. Khatib, S.A. Snyder, A.O. Ragheb, J.K. White, L.S. Machan, P.T.X.I. Zilver, Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results, Circ Cardiovasc Interv, 4 (2011) 495-504.
[24] C. Chaabane, F. Otsuka, R. Virmani, M.L. Bochaton-Piallat, Biological responses in stented arteries, Cardiovasc Res, 99 (2013) 353-363.
[25] J.C. George, E.S. Rosen, J. Nachtigall, A. VanHise, R. Kovach, SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study, J Vasc Interv Radiol, 25 (2014) 954-961.
[26] D. Scheinert, M. Werner, S. Scheinert, A. Paetzold, U. Banning-Eichenseer, M. Piorkowski, M. Ulrich, Y. Bausback, S. Braunlich, A. Schmidt, Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry, JACC Cardiovasc Interv, 6 (2013) 65-71.
[27] B.A. Mohd Atan, A.E. Ismail, I. Taib, Z. Lazim, A review on fracture prevention of stent in femoropopliteal artery, IOP Conference Series: Materials Science and Engineering, 165 (2017) 012006.
[28] J. Litsky, A. Chanda, E. Stilp, A. Lansky, C. Mena, Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent, Med Devices (Auckl), 7 (2014) 149-156.
[29] A.J. Klein, D.S. Pinto, B.H. Gray, M.R. Jaff, C.J. White, D.E. Drachman, A. Peripheral Vascular Disease Committee for the Society for Cardiovascular, Interventions, SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use, Catheter Cardiovasc Interv, 84 (2014) 529-538.
[30] C. Gokgol, N. Diehm, F.R. Nezami, P. Buchler, Nitinol Stent Oversizing in Patients Undergoing Popliteal Artery Revascularization: A Finite Element Study, Ann Biomed Eng, 43 (2015) 2868-2880.